NIH Funding Opportunities (Notices, PA, RFA)

Subscribe to NIH Funding Opportunities (Notices, PA, RFA) feed
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 2 hours 29 min ago

NIH HEAL Initiative PainCare Clinician Training Program (PCTP): Mentored Clinical Scientist Development Awards (K08 - Clinical Trials Not Allowed)

Fri, 2024-06-28 12:23
Funding Opportunity PAR-24-219 from the NIH Guide for Grants and Contracts. The purpose of this NIH HEAL Initiative PAINCare Clinician Training Program: PCTP): Mentored Clinical Scientist Development Awards (K08) (Clinical Trials Not Allowed)is to support a cohort of new and well-trained, independent investigators. The program will provide independent NIH research support during the early-career phase to help awardeesestablish independent research programs in areas support by the NIH HEAL InitiativesClinicalResearch in Pain Management program.

NIH HEAL Initiative PainCare Clinician Training Program (PCTP): Mentored Clinical Scientist Development Awards (K08 - Basic Experimental Studies with Humans (BESH) Required)

Fri, 2024-06-28 12:22
Funding Opportunity PAR-24-218 from the NIH Guide for Grants and Contracts. The purpose of this NIH HEAL Initiative PAINCare Clinician Training Program(PCTP): Mentored Clinical Scientist Development Awards (K08) (BESH)is to support a cohort of new and well-trained, independent investigators. The program will provide independent NIH research support during the early-career phase to help awardeesestablish independent research programs in areas support by the NIH HEAL InitiativesClinicalResearch in Pain Management program.

NIMH Research Education Mentoring Program for HIV Researchers (R25 Clinical Trial Not Allowed)

Thu, 2024-06-27 13:03
Funding Opportunity PAR-24-233 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this National Institute of Mental Health (NIMH) R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs and advance the priorities outlined in the Office of AIDS Research (OAR) Annual Strategic Plan and the research program priorities of the NIMH Division of AIDS Research (DAR). To accomplish the stated over-arching goal, this NOFO will support creative educational activities with a primary focus on Research Experiences and Mentoring Activities that either capitalize on existing networks of collaborating investigators or develop institute-based research education programs. Both research experiences and mentoring activities are required; research experiences are expected to be primary. Research Education Programs are expected to enhance the professional development of the participants and foster a career trajectory towards independent research in the mental health of HIV/AIDS.

NIH HEAL Initiative PainCare Clinician Training Program (PCTP): Mentored Clinical Scientist Development Awards (K08 - Clinical Trials Required)

Thu, 2024-06-27 12:21
Funding Opportunity PAR-24-217 from the NIH Guide for Grants and Contracts. The purpose of this NIH HEAL Initiative PAIN Care Clinician Training Program: PCTP): Mentored Clinical Scientist Development Awards (K08) (Clinical Trials Required) is to support a cohort of new and well-trained, independent investigators. The program will provide independent NIH research support during the early-career phase to help awardees establish independent research programs in areas support by the NIH HEAL Initiatives Clinical Research in Pain Management program.

Combined Neuromodulation and Behavioral Treatment Algorithm Development for Stimulant Use Disorder (StUD) Enriched for Vulnerable Phenotype (U01 Clinical Trial Required)

Thu, 2024-06-27 11:33
Funding Opportunity RFA-DA-25-057 from the NIH Guide for Grants and Contracts. Stimulant Use Disorder still does not have FDA- approved treatments. Neuromodulation, such as, for example, transcranial magnetic stimulation (TMC) has been successfully used for more than 10 years in major depressive disorder (MDD) where patients have failed one antidepressant and since 2018 it has been used for obsessive-compulsive disorder (OCD). Another example is transcranial direct current stimulation (tDCS) which is currently being developed for a range of mental and neurological conditions, and some of them have direct relevance for StUD vulnerable phenotype (cognitive dysfunction, compulsive, and impulsive traits). Other neuromodulation technologies potentially can also be applied to StUD. As not everyone who takes drugs becomes addicted, and while the StUD population's extreme heterogeneity represents a barrier to effective treatment development, there is a treatment gap that needs to be filled, especially for the high-risk vulnerable phenotype with low executive function and difficulties with response regulation - anxious-impulsive traits. Developing neuromodulation combined with behavioral treatment modalities (CBT, mindfulness-based approaches) that will help to maintain use decrease and prevent relapse would have tremendous value as a treatment option. Randomized controlled trials are needed to develop the treatment algorithms and to select the most efficacious one.

Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed)

Thu, 2024-06-27 11:33
Funding Opportunity PAR-24-244 from the NIH Guide for Grants and Contracts. The purpose of this notice of funding opportunity (NOFO) is to encourage community-engaged research that broadens the conceptualization of qualities of the environment that can support language development in children and that focuses on the development of novel measures of childrens language development. The overall goal is to build the number of strengths-focused, culturally and linguistically responsive, and generalizable toolsto further our understanding of childrens language development and/or impairment, and predictors thereof.

Advancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed)

Thu, 2024-06-27 11:30
Funding Opportunity PAR-24-243 from the NIH Guide for Grants and Contracts. The purpose of this notice of funding opportunity (NOFO) is to encourage community-engaged research that broadens the conceptualization of qualities of the environment that can support language development in children and that focuses on the development of novel measures of childrens language development. The overall goal is to build the number of strengths-focused, culturally and linguistically responsive, and generalizable toolsto further our understanding of childrens language development and/or impairment, and predictors thereof.

B-INSPIRE: Research on Behavioral Interventions that Promote Careers in the Biomedical Research Enterprise (R01 - Clinical Trial Not Allowed)

Thu, 2024-06-27 11:30
Funding Opportunity PAR-24-230 from the NIH Guide for Grants and Contracts. The B-INSPIRE: Research on Behavioral INterventionS that Promote Careers In the Biomedical Research Enterprise Notice of Funding Opportunity (NOFO) encourages applications that propose research designed to conduct studies of behavioral interventions to enhance research-oriented individuals' interest, motivation, persistence and preparedness for careers in the biomedical research workforce. Applications that propose conducting secondary data analysis of rigorous interventions, leveraging existing intervention cohorts, using new or advanced methods of analysis of rigorous intervention datasets, or general novel combinations and integration of rigorous intervention datasets for analysis, are also encouraged. Funded projects are expected to produce research findings that will guide the implementation of behavioral interventions in a variety of academic settings and career levels to enhance the diversity of the biomedical research workforce.

Individually Measured Phenotypes to Advance Computational Translation in Mental Health (IMPACT-MH) (U01 Clinical Trial Optional)

Wed, 2024-06-26 11:32
Funding Opportunity RFA-MH-25-195 from the NIH Guide for Grants and Contracts. This NOFO aims to encourage research using novel behavioral measures to foster a new generation of clinical signatures, leading toward precision assessment, prognosis, and treatment of mental disorders. The initial focus will be to (1) develop or optimize behavioral tasks that measure individual differences and demonstrate added utility for clinical prediction when combined with standard clinical diagnosis; (2) form a data infrastructure that can support computational approaches to build tools for clinical decision making.

Notice of Clarification to PAR-21-293 "Clinical and Translational Science Award (UM1 Clinical Trial Optional)"

Wed, 2024-06-26 05:34
Notice NOT-TR-24-029 from the NIH Guide for Grants and Contracts

Pages